NCT04460053View on ClinicalTrials.gov

Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

September 18, 2020

Study Completion Date

October 25, 2020

Conditions
Malignant Melanoma
Interventions
PROCEDURE

Neurofilament light protein measurement in Isolated limb perfused patients

A prospective feasibility trial measuring neurofilament light protein in peripheral blood as a biomarker for neurotoxicity after isolated limb perfusion.

Trial Locations (1)

413 45

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT04460053 - Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion. | Biotech Hunter | Biotech Hunter